Methylene blue has been shown to shrink tumours and slow cancer
growth by targeting cancer cell metabolism and energy production.
Photodynamic
therapy with methylene blue uses light activation to destroy cancer
cells while leaving healthy cells unharmed, making it a more precise
treatment option.
Research on ovarian cancer found that
methylene blue forces tumours to shift away from their preferred energy
source, making them more vulnerable to treatment.
Unlike
chemotherapy, methylene blue treatment does not cause significant side
effects or toxicity, making it a promising option for patients with
drug-resistant cancers.
Proper dosing is important. Just 5 milligrams of pharmaceutical-grade methylene blue per day is enough to reduce cellular stress and support mitochondrial health....<<<Read More>>>...
